Article Information
History
- August 30, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Roman M. Shapiro1,
- Grace Birch1,
- Juliana Vergara1,
- Guangan Hu2,
- Sarah Nikiforow1,
- Joanna Baginska3,
- Alaa Ali1,
- Mubin Tarannum1,
- Benedetta Rambaldi1,
- Yohei Arihara1,
- Carol Reynolds1,
- Max Halpern1,
- Scott Rodig4,
- Nicole Cullen4,
- Andrew A. Lane5,
- R. Coleman Lindsley5,
- Corey S. Cutler1,
- Joseph H. Antin1,
- Vincent T. Ho1,
- John Koreth1,
- Mahasweta Gooptu1,
- Haesook T. Kim6,
- Karl-Johan Malmberg7,8,
- Catherine J. Wu1,
- Jianzhu Chen2,
- Robert J. Soiffer1,
- Jerome Ritz1 and
- Rizwan Romee1,*
- 1Division of Transplantation and Cellular Therapies, Dana Farber Cancer Institute, Harvard Medical School
- 2Koch Institute, Massachusetts Institute of Technology
- 3Center for Immuno-oncology, Dana Farber Cancer Institute, Harvard Medical School
- 4Department of Pathology, Dana Farber Cancer Institute, Harvard Medical School
- 5Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School
- 6Department of Data Science, DFCI / Harvard T. H. Chan School of Public Health
- 7Department of Cancer Immunology, Oslo University Hospital
- 8Center for Infectious Medicine, Department of Medicine, Karolinska Institutet
- ↵*Correspondence:
Rizwan Romee, MD, 450 Brookline Ave, Boston, MA 02215, Phone: 617-632-3470, Email: rizwan_romee{at}dfci.harvard.edu